Autoimmune Disease Diagnostics Market Size, Share & Growth Graph by 2034

Table Of Content

Executive Summary

Research Scope & Segmentation

Research Objectives
Limitations & Assumptions
Market Scope & Segmentation
Currency & Pricing Considered

Market Opportunity Assessment

Emerging Regions / Countries
Emerging Companies
Emerging Applications / End Use

Market Trends

Drivers
Market Warning Factors
Latest Macro Economic Indicators
Geopolitical Impact
Technology Factors

Market Assessment

Porters Five Forces Analysis
Value Chain Analysis

Regulatory Framework

North America
Europe
APAC
Middle East and Africa
LATAM

ESG Trends

Global Autoimmune Disease Diagnostics Market Size Analysis

Global Autoimmune Disease Diagnostics Market Introduction
By Diagnostic Type
1. Introduction
  1. Diagnostic Type By Value
2. Systemic Autoimmune Disease Diagnostics
  1. By Value
  2. Rheumatoid Arthritis
    1. Rheumatoid Arthritis By Value
  3. Ankylosing Spondylitis
    1. Ankylosing Spondylitis By Value
  4. Systemic Lupus Erythematosus (SLE)
    1. Systemic Lupus Erythematosus (SLE) By Value
  5. Others
    1. Others By Value
3. Localized Autoimmune Disease Diagnostics
  1. By Value
  2. Multiple Sclerosis
    1. Multiple Sclerosis By Value
  3. Type 1 Diabetes
    1. Type 1 Diabetes By Value
  4. Hashimoto's Thyroiditis
    1. Hashimoto's Thyroiditis By Value
  5. Idiopathic Thrombocytopenic Purpura
    1. Idiopathic Thrombocytopenic Purpura By Value
  6. Others
    1. Others By Value
By Product Type
1. Introduction
  1. Product Type By Value
2. Instruments
  1. By Value
3. Consumables and Assays
  1. By Value
By Test Type
1. Introduction
  1. Test Type By Value
2. Antinuclear Antibody Tests
  1. By Value
3. Autoantibody Tests
  1. By Value
4. C-reactive Protein (CRP)
  1. By Value
5. Complete Blood Count (CBC)
  1. By Value
6. Urinalysis
  1. By Value
7. Others
  1. By Value
By End Use
1. Introduction
  1. End Use By Value
2. Hospitals
  1. By Value
3. Diagnostic Centers
  1. By Value
4. Others
  1. By Value

North America Market Analysis

Introduction
By Diagnostic Type
1. Introduction
  1. Diagnostic Type By Value
2. Systemic Autoimmune Disease Diagnostics
  1. By Value
  2. Rheumatoid Arthritis
    1. Rheumatoid Arthritis By Value
  3. Ankylosing Spondylitis
    1. Ankylosing Spondylitis By Value
  4. Systemic Lupus Erythematosus (SLE)
    1. Systemic Lupus Erythematosus (SLE) By Value
  5. Others
    1. Others By Value
3. Localized Autoimmune Disease Diagnostics
  1. By Value
  2. Multiple Sclerosis
    1. Multiple Sclerosis By Value
  3. Type 1 Diabetes
    1. Type 1 Diabetes By Value
  4. Hashimoto's Thyroiditis
    1. Hashimoto's Thyroiditis By Value
  5. Idiopathic Thrombocytopenic Purpura
    1. Idiopathic Thrombocytopenic Purpura By Value
  6. Others
    1. Others By Value
By Product Type
1. Introduction
  1. Product Type By Value
2. Instruments
  1. By Value
3. Consumables and Assays
  1. By Value
By Test Type
1. Introduction
  1. Test Type By Value
2. Antinuclear Antibody Tests
  1. By Value
3. Autoantibody Tests
  1. By Value
4. C-reactive Protein (CRP)
  1. By Value
5. Complete Blood Count (CBC)
  1. By Value
6. Urinalysis
  1. By Value
7. Others
  1. By Value
By End Use
1. Introduction
  1. End Use By Value
2. Hospitals
  1. By Value
3. Diagnostic Centers
  1. By Value
4. Others
  1. By Value
U.S.
1. By Diagnostic Type
  1. Introduction
    1. Diagnostic Type By Value
  2. Systemic Autoimmune Disease Diagnostics
    1. By Value
    2. Rheumatoid Arthritis
      1. Rheumatoid Arthritis By Value
    3. Ankylosing Spondylitis
      1. Ankylosing Spondylitis By Value
    4. Systemic Lupus Erythematosus (SLE)
      1. Systemic Lupus Erythematosus (SLE) By Value
    5. Others
      1. Others By Value
  3. Localized Autoimmune Disease Diagnostics
    1. By Value
    2. Multiple Sclerosis
      1. Multiple Sclerosis By Value
    3. Type 1 Diabetes
      1. Type 1 Diabetes By Value
    4. Hashimoto's Thyroiditis
      1. Hashimoto's Thyroiditis By Value
    5. Idiopathic Thrombocytopenic Purpura
      1. Idiopathic Thrombocytopenic Purpura By Value
    6. Others
      1. Others By Value
2. By Product Type
  1. Introduction
    1. Product Type By Value
  2. Instruments
    1. By Value
  3. Consumables and Assays
    1. By Value
3. By Test Type
  1. Introduction
    1. Test Type By Value
  2. Antinuclear Antibody Tests
    1. By Value
  3. Autoantibody Tests
    1. By Value
  4. C-reactive Protein (CRP)
    1. By Value
  5. Complete Blood Count (CBC)
    1. By Value
  6. Urinalysis
    1. By Value
  7. Others
    1. By Value
4. By End Use
  1. Introduction
    1. End Use By Value
  2. Hospitals
    1. By Value
  3. Diagnostic Centers
    1. By Value
  4. Others
    1. By Value
Canada

Europe Market Analysis

Introduction
By Diagnostic Type
1. Introduction
  1. Diagnostic Type By Value
2. Systemic Autoimmune Disease Diagnostics
  1. By Value
  2. Rheumatoid Arthritis
    1. Rheumatoid Arthritis By Value
  3. Ankylosing Spondylitis
    1. Ankylosing Spondylitis By Value
  4. Systemic Lupus Erythematosus (SLE)
    1. Systemic Lupus Erythematosus (SLE) By Value
  5. Others
    1. Others By Value
3. Localized Autoimmune Disease Diagnostics
  1. By Value
  2. Multiple Sclerosis
    1. Multiple Sclerosis By Value
  3. Type 1 Diabetes
    1. Type 1 Diabetes By Value
  4. Hashimoto's Thyroiditis
    1. Hashimoto's Thyroiditis By Value
  5. Idiopathic Thrombocytopenic Purpura
    1. Idiopathic Thrombocytopenic Purpura By Value
  6. Others
    1. Others By Value
By Product Type
1. Introduction
  1. Product Type By Value
2. Instruments
  1. By Value
3. Consumables and Assays
  1. By Value
By Test Type
1. Introduction
  1. Test Type By Value
2. Antinuclear Antibody Tests
  1. By Value
3. Autoantibody Tests
  1. By Value
4. C-reactive Protein (CRP)
  1. By Value
5. Complete Blood Count (CBC)
  1. By Value
6. Urinalysis
  1. By Value
7. Others
  1. By Value
By End Use
1. Introduction
  1. End Use By Value
2. Hospitals
  1. By Value
3. Diagnostic Centers
  1. By Value
4. Others
  1. By Value
U.K.
1. By Diagnostic Type
  1. Introduction
    1. Diagnostic Type By Value
  2. Systemic Autoimmune Disease Diagnostics
    1. By Value
    2. Rheumatoid Arthritis
      1. Rheumatoid Arthritis By Value
    3. Ankylosing Spondylitis
      1. Ankylosing Spondylitis By Value
    4. Systemic Lupus Erythematosus (SLE)
      1. Systemic Lupus Erythematosus (SLE) By Value
    5. Others
      1. Others By Value
  3. Localized Autoimmune Disease Diagnostics
    1. By Value
    2. Multiple Sclerosis
      1. Multiple Sclerosis By Value
    3. Type 1 Diabetes
      1. Type 1 Diabetes By Value
    4. Hashimoto's Thyroiditis
      1. Hashimoto's Thyroiditis By Value
    5. Idiopathic Thrombocytopenic Purpura
      1. Idiopathic Thrombocytopenic Purpura By Value
    6. Others
      1. Others By Value
2. By Product Type
  1. Introduction
    1. Product Type By Value
  2. Instruments
    1. By Value
  3. Consumables and Assays
    1. By Value
3. By Test Type
  1. Introduction
    1. Test Type By Value
  2. Antinuclear Antibody Tests
    1. By Value
  3. Autoantibody Tests
    1. By Value
  4. C-reactive Protein (CRP)
    1. By Value
  5. Complete Blood Count (CBC)
    1. By Value
  6. Urinalysis
    1. By Value
  7. Others
    1. By Value
4. By End Use
  1. Introduction
    1. End Use By Value
  2. Hospitals
    1. By Value
  3. Diagnostic Centers
    1. By Value
  4. Others
    1. By Value
Germany
France
Spain
Italy
Russia
Nordic
Benelux
Rest of Europe

APAC Market Analysis

Introduction
By Diagnostic Type
1. Introduction
  1. Diagnostic Type By Value
2. Systemic Autoimmune Disease Diagnostics
  1. By Value
  2. Rheumatoid Arthritis
    1. Rheumatoid Arthritis By Value
  3. Ankylosing Spondylitis
    1. Ankylosing Spondylitis By Value
  4. Systemic Lupus Erythematosus (SLE)
    1. Systemic Lupus Erythematosus (SLE) By Value
  5. Others
    1. Others By Value
3. Localized Autoimmune Disease Diagnostics
  1. By Value
  2. Multiple Sclerosis
    1. Multiple Sclerosis By Value
  3. Type 1 Diabetes
    1. Type 1 Diabetes By Value
  4. Hashimoto's Thyroiditis
    1. Hashimoto's Thyroiditis By Value
  5. Idiopathic Thrombocytopenic Purpura
    1. Idiopathic Thrombocytopenic Purpura By Value
  6. Others
    1. Others By Value
By Product Type
1. Introduction
  1. Product Type By Value
2. Instruments
  1. By Value
3. Consumables and Assays
  1. By Value
By Test Type
1. Introduction
  1. Test Type By Value
2. Antinuclear Antibody Tests
  1. By Value
3. Autoantibody Tests
  1. By Value
4. C-reactive Protein (CRP)
  1. By Value
5. Complete Blood Count (CBC)
  1. By Value
6. Urinalysis
  1. By Value
7. Others
  1. By Value
By End Use
1. Introduction
  1. End Use By Value
2. Hospitals
  1. By Value
3. Diagnostic Centers
  1. By Value
4. Others
  1. By Value
China
1. By Diagnostic Type
  1. Introduction
    1. Diagnostic Type By Value
  2. Systemic Autoimmune Disease Diagnostics
    1. By Value
    2. Rheumatoid Arthritis
      1. Rheumatoid Arthritis By Value
    3. Ankylosing Spondylitis
      1. Ankylosing Spondylitis By Value
    4. Systemic Lupus Erythematosus (SLE)
      1. Systemic Lupus Erythematosus (SLE) By Value
    5. Others
      1. Others By Value
  3. Localized Autoimmune Disease Diagnostics
    1. By Value
    2. Multiple Sclerosis
      1. Multiple Sclerosis By Value
    3. Type 1 Diabetes
      1. Type 1 Diabetes By Value
    4. Hashimoto's Thyroiditis
      1. Hashimoto's Thyroiditis By Value
    5. Idiopathic Thrombocytopenic Purpura
      1. Idiopathic Thrombocytopenic Purpura By Value
    6. Others
      1. Others By Value
2. By Product Type
  1. Introduction
    1. Product Type By Value
  2. Instruments
    1. By Value
  3. Consumables and Assays
    1. By Value
3. By Test Type
  1. Introduction
    1. Test Type By Value
  2. Antinuclear Antibody Tests
    1. By Value
  3. Autoantibody Tests
    1. By Value
  4. C-reactive Protein (CRP)
    1. By Value
  5. Complete Blood Count (CBC)
    1. By Value
  6. Urinalysis
    1. By Value
  7. Others
    1. By Value
4. By End Use
  1. Introduction
    1. End Use By Value
  2. Hospitals
    1. By Value
  3. Diagnostic Centers
    1. By Value
  4. Others
    1. By Value
Korea
Japan
India
Australia
Taiwan
South East Asia
Rest of Asia-Pacific

Middle East and Africa Market Analysis

Introduction
By Diagnostic Type
1. Introduction
  1. Diagnostic Type By Value
2. Systemic Autoimmune Disease Diagnostics
  1. By Value
  2. Rheumatoid Arthritis
    1. Rheumatoid Arthritis By Value
  3. Ankylosing Spondylitis
    1. Ankylosing Spondylitis By Value
  4. Systemic Lupus Erythematosus (SLE)
    1. Systemic Lupus Erythematosus (SLE) By Value
  5. Others
    1. Others By Value
3. Localized Autoimmune Disease Diagnostics
  1. By Value
  2. Multiple Sclerosis
    1. Multiple Sclerosis By Value
  3. Type 1 Diabetes
    1. Type 1 Diabetes By Value
  4. Hashimoto's Thyroiditis
    1. Hashimoto's Thyroiditis By Value
  5. Idiopathic Thrombocytopenic Purpura
    1. Idiopathic Thrombocytopenic Purpura By Value
  6. Others
    1. Others By Value
By Product Type
1. Introduction
  1. Product Type By Value
2. Instruments
  1. By Value
3. Consumables and Assays
  1. By Value
By Test Type
1. Introduction
  1. Test Type By Value
2. Antinuclear Antibody Tests
  1. By Value
3. Autoantibody Tests
  1. By Value
4. C-reactive Protein (CRP)
  1. By Value
5. Complete Blood Count (CBC)
  1. By Value
6. Urinalysis
  1. By Value
7. Others
  1. By Value
By End Use
1. Introduction
  1. End Use By Value
2. Hospitals
  1. By Value
3. Diagnostic Centers
  1. By Value
4. Others
  1. By Value
UAE
1. By Diagnostic Type
  1. Introduction
    1. Diagnostic Type By Value
  2. Systemic Autoimmune Disease Diagnostics
    1. By Value
    2. Rheumatoid Arthritis
      1. Rheumatoid Arthritis By Value
    3. Ankylosing Spondylitis
      1. Ankylosing Spondylitis By Value
    4. Systemic Lupus Erythematosus (SLE)
      1. Systemic Lupus Erythematosus (SLE) By Value
    5. Others
      1. Others By Value
  3. Localized Autoimmune Disease Diagnostics
    1. By Value
    2. Multiple Sclerosis
      1. Multiple Sclerosis By Value
    3. Type 1 Diabetes
      1. Type 1 Diabetes By Value
    4. Hashimoto's Thyroiditis
      1. Hashimoto's Thyroiditis By Value
    5. Idiopathic Thrombocytopenic Purpura
      1. Idiopathic Thrombocytopenic Purpura By Value
    6. Others
      1. Others By Value
2. By Product Type
  1. Introduction
    1. Product Type By Value
  2. Instruments
    1. By Value
  3. Consumables and Assays
    1. By Value
3. By Test Type
  1. Introduction
    1. Test Type By Value
  2. Antinuclear Antibody Tests
    1. By Value
  3. Autoantibody Tests
    1. By Value
  4. C-reactive Protein (CRP)
    1. By Value
  5. Complete Blood Count (CBC)
    1. By Value
  6. Urinalysis
    1. By Value
  7. Others
    1. By Value
4. By End Use
  1. Introduction
    1. End Use By Value
  2. Hospitals
    1. By Value
  3. Diagnostic Centers
    1. By Value
  4. Others
    1. By Value
Turkey
Saudi Arabia
South Africa
Egypt
Nigeria
Rest of MEA

LATAM Market Analysis

Introduction
By Diagnostic Type
1. Introduction
  1. Diagnostic Type By Value
2. Systemic Autoimmune Disease Diagnostics
  1. By Value
  2. Rheumatoid Arthritis
    1. Rheumatoid Arthritis By Value
  3. Ankylosing Spondylitis
    1. Ankylosing Spondylitis By Value
  4. Systemic Lupus Erythematosus (SLE)
    1. Systemic Lupus Erythematosus (SLE) By Value
  5. Others
    1. Others By Value
3. Localized Autoimmune Disease Diagnostics
  1. By Value
  2. Multiple Sclerosis
    1. Multiple Sclerosis By Value
  3. Type 1 Diabetes
    1. Type 1 Diabetes By Value
  4. Hashimoto's Thyroiditis
    1. Hashimoto's Thyroiditis By Value
  5. Idiopathic Thrombocytopenic Purpura
    1. Idiopathic Thrombocytopenic Purpura By Value
  6. Others
    1. Others By Value
By Product Type
1. Introduction
  1. Product Type By Value
2. Instruments
  1. By Value
3. Consumables and Assays
  1. By Value
By Test Type
1. Introduction
  1. Test Type By Value
2. Antinuclear Antibody Tests
  1. By Value
3. Autoantibody Tests
  1. By Value
4. C-reactive Protein (CRP)
  1. By Value
5. Complete Blood Count (CBC)
  1. By Value
6. Urinalysis
  1. By Value
7. Others
  1. By Value
By End Use
1. Introduction
  1. End Use By Value
2. Hospitals
  1. By Value
3. Diagnostic Centers
  1. By Value
4. Others
  1. By Value
Brazil
1. By Diagnostic Type
  1. Introduction
    1. Diagnostic Type By Value
  2. Systemic Autoimmune Disease Diagnostics
    1. By Value
    2. Rheumatoid Arthritis
      1. Rheumatoid Arthritis By Value
    3. Ankylosing Spondylitis
      1. Ankylosing Spondylitis By Value
    4. Systemic Lupus Erythematosus (SLE)
      1. Systemic Lupus Erythematosus (SLE) By Value
    5. Others
      1. Others By Value
  3. Localized Autoimmune Disease Diagnostics
    1. By Value
    2. Multiple Sclerosis
      1. Multiple Sclerosis By Value
    3. Type 1 Diabetes
      1. Type 1 Diabetes By Value
    4. Hashimoto's Thyroiditis
      1. Hashimoto's Thyroiditis By Value
    5. Idiopathic Thrombocytopenic Purpura
      1. Idiopathic Thrombocytopenic Purpura By Value
    6. Others
      1. Others By Value
2. By Product Type
  1. Introduction
    1. Product Type By Value
  2. Instruments
    1. By Value
  3. Consumables and Assays
    1. By Value
3. By Test Type
  1. Introduction
    1. Test Type By Value
  2. Antinuclear Antibody Tests
    1. By Value
  3. Autoantibody Tests
    1. By Value
  4. C-reactive Protein (CRP)
    1. By Value
  5. Complete Blood Count (CBC)
    1. By Value
  6. Urinalysis
    1. By Value
  7. Others
    1. By Value
4. By End Use
  1. Introduction
    1. End Use By Value
  2. Hospitals
    1. By Value
  3. Diagnostic Centers
    1. By Value
  4. Others
    1. By Value
Mexico
Argentina
Chile
Colombia
Rest of LATAM

Competitive Landscape

Autoimmune Disease Diagnostics Market Share By Players
M&A Agreements & Collaboration Analysis

Market Players Assessment

Hoffmann-La Roche Ltd
1. Overview
2. Business Information
3. Revenue
4. ASP
5. SWOT Analysis
6. Recent Developments
Siemens Healthineers AG
Abbott
Beckman Coulter, Inc.
Danaher Corporation
Quest Diagnostics
EUROIMMUN Medizinische Labordiagnostika AG
Nova Diagnostics Pte Ltd.
BIOMÉRIEUX
Hemagen Diagnostics, Inc.
Lal PathLabs

Research Methodology

Research Data
1. Secondary Data
  1. Major secondary sources
  2. Key data from secondary sources
2. Primary Data
  1. Key data from primary sources
  2. Breakdown of primaries
3. Secondary And Primary Research
  1. Key industry insights
Market Size Estimation
1. Bottom-Up Approach
2. Top-Down Approach
3. Market Projection
Research Assumptions
1. Assumptions
Limitations
Risk Assessment